{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:45:49Z","timestamp":1789562749900,"version":"build-2803163510"},"reference-count":33,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T00:00:00Z","timestamp":1491523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain and Behavior"],"published-print":{"date-parts":[[2017,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      To determine the possible interactions between levodopa therapy and plasma levels of B vitamins in patients with advanced idiopathic Parkinson's disease (\n                      <jats:styled-content style=\"fixed-case\">IPD<\/jats:styled-content>\n                      ) in the context of either oral levodopa therapy or levodopa\/carbidopa intestinal gel (\n                      <jats:styled-content style=\"fixed-case\">LCIG<\/jats:styled-content>\n                      ). Secondly, to determine the prevalence of neuropathy and its relation to plasma levels of B vitamins and homocysteine.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Medication doses, neurographies, and serum levels of pyridoxine, cobalamin, folate, and homocysteine of eight\n                      <jats:styled-content style=\"fixed-case\">LCIG<\/jats:styled-content>\n                      and 13 orally treated advanced\n                      <jats:styled-content style=\"fixed-case\">IPD<\/jats:styled-content>\n                      patients matched for age, Hoehn &amp; Yahr stage, and\n                      <jats:styled-content style=\"fixed-case\">UPRDS III<\/jats:styled-content>\n                      were collected. This data was analyzed for correlation with daily levodopa dose (\n                      <jats:styled-content style=\"fixed-case\">LDD<\/jats:styled-content>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:styled-content style=\"fixed-case\">LICG<\/jats:styled-content>\n                      patients had a longer disease duration and higher\n                      <jats:styled-content style=\"fixed-case\">LDD<\/jats:styled-content>\n                      . All\n                      <jats:styled-content style=\"fixed-case\">LCIG<\/jats:styled-content>\n                      patients and most orally treated patients had sensorimotor axonal polyneuropathy. Of all plasma vitamin levels, pyridoxine was decreased most and significantly lower in the\n                      <jats:styled-content style=\"fixed-case\">LCIG<\/jats:styled-content>\n                      group. Cobalamin and folate, however, were within the lower reference range, and homocysteine highly elevated, all without any significant difference between both groups.\n                      <jats:styled-content style=\"fixed-case\">LDD<\/jats:styled-content>\n                      correlated significantly with pyridoxine deficiency (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a0.02) irrespective of the route of application and with hyperhomocysteinemia in the\n                      <jats:styled-content style=\"fixed-case\">LCIG<\/jats:styled-content>\n                      group (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a0.03). At\n                      <jats:styled-content style=\"fixed-case\">LDD<\/jats:styled-content>\n                      s above 2,000\u00a0mg, pyridoxine deficiency was almost always detectable.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Pyridoxine deficiency and hyperhomocysteinemia are dependent on the daily levodopa\/carbidopa dose, while levels of cobalamin and folate are not. The mode of application of levodopa\/carbidopa has no impact on B\u2010vitamin levels. Neuropathy is very frequent in advanced\n                      <jats:styled-content style=\"fixed-case\">IPD<\/jats:styled-content>\n                      ; however, it remains to be investigated further whether neuropathy is more frequent in\n                      <jats:styled-content style=\"fixed-case\">LCIG<\/jats:styled-content>\n                      than in orally levodopa\/carbidopa\u2010treated advanced\n                      <jats:styled-content style=\"fixed-case\">IPD<\/jats:styled-content>\n                      patients.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/brb3.698","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T08:18:56Z","timestamp":1491553136000},"source":"Crossref","is-referenced-by-count":56,"title":["Effects of levodopa\/carbidopa intestinal gel versus oral levodopa\/carbidopa on B vitamin levels and neuropathy"],"prefix":"10.1002","volume":"7","author":[{"given":"Sebastian","family":"Loens","sequence":"first","affiliation":[{"name":"Department of Neurology and Clinical Neurophysiology Hannover Medical School  Hannover Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Chorbadzhieva","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Neurophysiology Hannover Medical School  Hannover Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Kleimann","sequence":"additional","affiliation":[{"name":"Department of Psychiatry Social Psychiatry and Psychotherapy Hannover Medical School  Hannover Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Dressler","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Neurophysiology Hannover Medical School  Hannover Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5323-8299","authenticated-orcid":false,"given":"Christoph","family":"Schrader","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Neurophysiology Hannover Medical School  Hannover Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,4,7]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2010.04.010"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21500"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.2174\/1874091X01206010131"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25585"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031610"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/wnf.0b013e31814b113e"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2012.11.020"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2013.08.007"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20210"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2013.02.002"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066639"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2013.05.002"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-011-0689-3"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2013.09.007"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12846"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12164"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000055899.24594.8E"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.WNF.0000236770.38903.AF"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.8.6.957"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.61.5.657"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2013.02.006"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-200305000-00010"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70293-X"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncpneuro0222"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31823a0ee4"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-013-7079-8"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23419"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2012.08.002"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu7095333"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23429"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22021"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22137"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23342"}],"container-title":["Brain and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fbrb3.698","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/brb3.698","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T15:51:40Z","timestamp":1696607500000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/brb3.698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,7]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["10.1002\/brb3.698"],"URL":"https:\/\/doi.org\/10.1002\/brb3.698","archive":["Portico"],"relation":{},"ISSN":["2162-3279","2162-3279"],"issn-type":[{"value":"2162-3279","type":"print"},{"value":"2162-3279","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,7]]},"article-number":"e00698"}}